WARNINGS The product, although presenting a very poor systemic absorption, should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. Keep out of the reach and sight of children as accidental ingestion can cause CNS depression (marked sedation or hypotonia). Since the product, in the 10 ml bottle, contains benzalkonium chloride, soft contact lenses should not be worn during treatment. Since benzalkonium chloride is not present in the single-dose package, this can be used by contact lens wearers, or by those who show hypersensitivity to benzalkonium chloride. PHARMACOTHERAPEUTIC CATEGORY Different ophthalmic antiseptics. STORAGE Eye drops, 10 ml bottle: Store in the original package. Validity after first opening: 30 days. Eye drops, single-dose container: store at a temperature not exceeding 30 degrees C, in the original package. The single-dose container does not contain preservatives; for this reason each single-dose container, once opened, must be thrown away after use, even if only partially used. CONTRAINDICATIONS / SECONDARY EFFECT It should not be used by people with narrow-angle glaucoma or other serious eye diseases. Hypersensitivity to the components or to other closely related substances from a chemical point of view. It should not be used in children under the age of twelve. Simultaneous treatment with monoamine oxidase inhibitors. NAME EYE DROPS ALPHA (R) ANTIHISTAMIN EXCIPIENTS Eye drops, 10 ml bottle: sodium chloride, sodium citrate, monobasic sodium citrate, sodium edetate, benzalkonium chloride, levomentol, ethyl alcohol, water for injections. Eye drops, single-dose container: sodium chloride, sodium citrate, monobasic sodium citrate, sodium edetate, levomentol, ethyl alcohol, water for injections. SIDE EFFECTS The use of the product can sometimes cause pupillary dilation, systemic absorption effects (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case it is necessary to interrupt the treatment and consult the doctor so that, if necessary, suitable therapy can be instituted. The patient is invited to report to the attending physician or pharmacist the possible appearance of undesirable effects not described. PREGNANCY AND BREASTFEEDING During pregnancy and lactation use only in case of real need, under the direct supervision of the doctor. INDICATIONS Allergic and inflammatory states of the conjunctiva, accompanied by photophobia, lacrimation, sensation of foreign bodies. INTERACTIONS The drug should not be used if you are taking monoamine oxidase inhibitor drugs or if less than two weeks have passed since the last administration of these drugs as serious hypertensive crises may arise. DOSAGE Instill 1-2 drops in the affected eye, up to 2-3 times a day, as needed. Strictly adhere to the recommended doses. A higher dosage of the product even if taken topically and for a short period of time can 'give rise to serious systemic effects. If symptoms persist or worsen after a short period of treatment, consult your doctor. In any case, the product should not be used for more than 4 consecutive days, unless otherwise prescribed, as undesirable effects may occur. ACTIVE PRINCIPLES 1 ml of solution contains: 1 mg tonzylamine hydrochloride, 0.8 mg naphazoline nitrate.